| BCBS Louisiana | remibrutinib (Rhapsido®) | 2026-04-01 |
| Ambetter Health Florida Clinical | Skin and Soft Tissue Substitutes | 2026-04-01 |
| Ambetter Health Kentucky WellCare Clinical | Skin and Soft Tissue Substitutes | 2026-04-01 |
| Ambetter Health Indiana Clinical | Skin and Soft Tissue Substitutes | 2026-04-01 |
| Ambetter Health Iowa Clinical | Skin and Soft Tissue Substitutes | 2026-04-01 |
| Ambetter Health Nevada Silver Summit Clinical | Skin and Soft Tissue Substitutes | 2026-04-01 |
| UHC Medicaid Medical & Drug | Alpha1-Proteinase Inhibitors – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Antiemetics for Oncology – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Benlysta® (Belimumab) – Community Plan Medical Benefit Drug Policy | 2026-04-01 |
| UHC Medicaid Medical & Drug | Botulinum Toxins A and B – Community Plan Medical Benefit Drug Policy | 2026-04-01 |